Bank Of New York Mellon Corp Oramed Pharmaceuticals Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $361,896 - $875,556	-97,284 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$8.19 - $13.89 $125,847 - $213,433	15,366 Added 18.76%	97,284 $842,000
Q4 2021 Feb 11, 2022	BUY	$12.98 - $29.75 $152,800 - $350,217	11,772 Added 16.78%	81,918 $1.17 Million
Q3 2021 Nov 12, 2021	BUY	$12.13 - $23.82 $209,145 - $410,704	17,242 Added 32.59%	70,146 $1.54 Million
Q2 2021 Aug 11, 2021	BUY	$8.34 - $14.59 $441,219 - $771,869	52,904 New	52,904 $707,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.